Emergent BioSolutions Inc (NYSE:EBS)

53.27
Delayed Data
As of Sep 18
 -0.05 / -0.09%
Today’s Change
39.11
Today|||52-Week Range
73.89
-10.14%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close53.32
Today’s open53.45
Day’s range52.68 - 53.56
Volume445,572
Average volume (3 months)421,752
Market cap$2.7B
Data as of 6:30pm ET, 09/18/2019

Growth & Valuation

Earnings growth (last year)-36.79%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+18.55%
Revenue growth (last year)+39.50%
P/E ratioNM
Price/Sales3.89
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Pharmaceut...-0.26-0.88%
CRSPCRISPR Therapeutics ...+0.18+0.37%
IOVAIovance Biotherapeut...-0.41-1.93%
TLRYTilray Inc-0.02-0.07%
Data as of 4:00pm ET, 09/18/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)$0.90
Annual revenue (last year)$782.4M
Annual profit (last year)$62.7M
Net profit margin8.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, COO &
Director
Robert G. Kramer
Chief Financial Officer, Treasurer &
Executive VP
Richard S. Lindahl
Corporate headquarters
Gaithersburg, Maryland

Forecasts